Amar Jayprakash Majmundar, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nephrotic Syndrome | 13 | 2021 | 381 | 1.730 |
Why?
|
| Nephrolithiasis | 3 | 2022 | 117 | 1.000 |
Why?
|
| Receptors, Purinergic P2 | 2 | 2022 | 152 | 0.940 |
Why?
|
| Podocytes | 8 | 2021 | 403 | 0.830 |
Why?
|
| Urinary Tract | 6 | 2023 | 305 | 0.740 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 4 | 2015 | 627 | 0.740 |
Why?
|
| Urogenital Abnormalities | 5 | 2023 | 255 | 0.730 |
Why?
|
| Receptors, Calcium-Sensing | 1 | 2021 | 320 | 0.690 |
Why?
|
| Kidney Calculi | 1 | 2021 | 458 | 0.560 |
Why?
|
| Nephrosis | 3 | 2021 | 43 | 0.490 |
Why?
|
| Muscle Development | 1 | 2015 | 258 | 0.430 |
Why?
|
| Kidney Diseases | 2 | 2021 | 2100 | 0.420 |
Why?
|
| Pedigree | 11 | 2021 | 4539 | 0.410 |
Why?
|
| Mutation | 17 | 2021 | 30238 | 0.380 |
Why?
|
| Microcephaly | 3 | 2021 | 426 | 0.360 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2011 | 125 | 0.360 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2021 | 2909 | 0.360 |
Why?
|
| Myoblasts | 1 | 2011 | 234 | 0.350 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 3 | 2012 | 1143 | 0.350 |
Why?
|
| Hernia, Hiatal | 2 | 2021 | 91 | 0.310 |
Why?
|
| Genetic Predisposition to Disease | 9 | 2021 | 18065 | 0.290 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2021 | 3610 | 0.250 |
Why?
|
| Mutation, Missense | 4 | 2022 | 2592 | 0.250 |
Why?
|
| Glucocorticoids | 3 | 2019 | 2167 | 0.240 |
Why?
|
| DNA Mutational Analysis | 8 | 2019 | 4120 | 0.230 |
Why?
|
| Drug Resistance | 3 | 2019 | 1599 | 0.230 |
Why?
|
| Membrane Proteins | 6 | 2021 | 7876 | 0.220 |
Why?
|
| Oxygen | 2 | 2015 | 4270 | 0.220 |
Why?
|
| Genetic Markers | 3 | 2019 | 2603 | 0.220 |
Why?
|
| Pakistan | 2 | 2021 | 299 | 0.220 |
Why?
|
| Actins | 2 | 2021 | 2064 | 0.210 |
Why?
|
| Stress, Physiological | 1 | 2010 | 1408 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2011 | 2457 | 0.210 |
Why?
|
| Kidney | 8 | 2023 | 7064 | 0.210 |
Why?
|
| Diabetes Insipidus, Nephrogenic | 1 | 2022 | 20 | 0.200 |
Why?
|
| Calcium Oxalate | 1 | 2022 | 75 | 0.200 |
Why?
|
| Zebrafish Proteins | 2 | 2019 | 1019 | 0.200 |
Why?
|
| Ketoglutaric Acids | 1 | 2022 | 76 | 0.200 |
Why?
|
| Developmental Disabilities | 2 | 2021 | 1518 | 0.200 |
Why?
|
| Gene Knockdown Techniques | 4 | 2021 | 1606 | 0.190 |
Why?
|
| Cell Hypoxia | 4 | 2012 | 662 | 0.190 |
Why?
|
| Polycystic Kidney, Autosomal Recessive | 1 | 2021 | 31 | 0.190 |
Why?
|
| Diabetes Insipidus | 1 | 2022 | 144 | 0.190 |
Why?
|
| Intranuclear Space | 1 | 2021 | 15 | 0.190 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 4978 | 0.170 |
Why?
|
| Repressor Proteins | 2 | 2021 | 2982 | 0.170 |
Why?
|
| Acidosis, Renal Tubular | 1 | 2019 | 50 | 0.170 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2020 | 279 | 0.160 |
Why?
|
| Genes, Dominant | 1 | 2021 | 855 | 0.160 |
Why?
|
| Collagen Type IV | 1 | 2019 | 125 | 0.160 |
Why?
|
| Vesico-Ureteral Reflux | 2 | 2021 | 433 | 0.150 |
Why?
|
| rab5 GTP-Binding Proteins | 1 | 2018 | 47 | 0.150 |
Why?
|
| Nephritis | 1 | 2019 | 147 | 0.150 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2019 | 195 | 0.150 |
Why?
|
| Cell Line | 6 | 2021 | 15597 | 0.150 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2021 | 336 | 0.140 |
Why?
|
| Nephrocalcinosis | 1 | 2017 | 51 | 0.140 |
Why?
|
| Laminin | 1 | 2019 | 405 | 0.140 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2018 | 165 | 0.140 |
Why?
|
| Oocytes | 1 | 2022 | 1172 | 0.140 |
Why?
|
| Genetic Association Studies | 4 | 2019 | 2744 | 0.140 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2018 | 235 | 0.140 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2019 | 270 | 0.140 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2019 | 2298 | 0.130 |
Why?
|
| Receptors, Nicotinic | 1 | 2019 | 494 | 0.130 |
Why?
|
| Forkhead Transcription Factors | 2 | 2020 | 1625 | 0.130 |
Why?
|
| Xenopus laevis | 4 | 2022 | 967 | 0.130 |
Why?
|
| Immunosuppressive Agents | 2 | 2019 | 4206 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2021 | 998 | 0.130 |
Why?
|
| Proteinuria | 1 | 2019 | 611 | 0.130 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2021 | 757 | 0.130 |
Why?
|
| Xenopus Proteins | 1 | 2018 | 435 | 0.130 |
Why?
|
| Animals | 21 | 2023 | 169246 | 0.130 |
Why?
|
| Phenotype | 8 | 2021 | 16726 | 0.120 |
Why?
|
| Microfilament Proteins | 1 | 2020 | 1133 | 0.120 |
Why?
|
| Transcription Factors | 4 | 2021 | 12168 | 0.120 |
Why?
|
| Mice | 13 | 2023 | 82029 | 0.120 |
Why?
|
| DNA-Binding Proteins | 3 | 2021 | 9615 | 0.120 |
Why?
|
| Ischemia | 2 | 2015 | 1900 | 0.120 |
Why?
|
| Child, Preschool | 14 | 2021 | 42669 | 0.120 |
Why?
|
| Congenital Abnormalities | 1 | 2019 | 703 | 0.110 |
Why?
|
| GTP-Binding Proteins | 1 | 2018 | 948 | 0.110 |
Why?
|
| Child | 16 | 2021 | 80917 | 0.110 |
Why?
|
| Signal Transduction | 4 | 2019 | 23645 | 0.100 |
Why?
|
| Zebrafish | 3 | 2019 | 3035 | 0.100 |
Why?
|
| Collateral Circulation | 1 | 2012 | 291 | 0.090 |
Why?
|
| Homozygote | 3 | 2021 | 1779 | 0.090 |
Why?
|
| Perfusion | 1 | 2015 | 1401 | 0.090 |
Why?
|
| Humans | 34 | 2023 | 768166 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 2 | 2015 | 2633 | 0.090 |
Why?
|
| Receptors, Notch | 2 | 2012 | 751 | 0.090 |
Why?
|
| Hindlimb | 1 | 2012 | 516 | 0.080 |
Why?
|
| Alleles | 4 | 2021 | 6894 | 0.080 |
Why?
|
| Genetic Variation | 2 | 2021 | 6611 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 4 | 2018 | 22379 | 0.080 |
Why?
|
| Xenopus | 2 | 2020 | 711 | 0.080 |
Why?
|
| Models, Biological | 2 | 2018 | 9495 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 1 | 2021 | 4413 | 0.070 |
Why?
|
| RNA | 1 | 2018 | 2720 | 0.070 |
Why?
|
| Endodeoxyribonucleases | 1 | 2009 | 165 | 0.070 |
Why?
|
| Carrier Proteins | 1 | 2021 | 4937 | 0.070 |
Why?
|
| Gene Deletion | 1 | 2015 | 2675 | 0.070 |
Why?
|
| Cohort Studies | 5 | 2021 | 41754 | 0.070 |
Why?
|
| Heredity | 2 | 2017 | 149 | 0.070 |
Why?
|
| Gene Knockout Techniques | 2 | 2021 | 806 | 0.070 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 3833 | 0.070 |
Why?
|
| Age of Onset | 3 | 2019 | 3347 | 0.070 |
Why?
|
| Infant | 8 | 2021 | 36535 | 0.070 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2019 | 2171 | 0.070 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2021 | 3671 | 0.070 |
Why?
|
| Regeneration | 1 | 2015 | 1524 | 0.070 |
Why?
|
| Cell Differentiation | 2 | 2015 | 11669 | 0.060 |
Why?
|
| Prognosis | 7 | 2019 | 30010 | 0.060 |
Why?
|
| RNA, Small Interfering | 3 | 2020 | 3428 | 0.060 |
Why?
|
| Amino Acid Substitution | 2 | 2021 | 1743 | 0.060 |
Why?
|
| Male | 18 | 2022 | 364719 | 0.060 |
Why?
|
| Epilepsy | 1 | 2021 | 3327 | 0.060 |
Why?
|
| Female | 20 | 2022 | 397192 | 0.060 |
Why?
|
| Animals, Genetically Modified | 2 | 2020 | 1563 | 0.060 |
Why?
|
| Gene Expression Profiling | 2 | 2019 | 9538 | 0.060 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 5889 | 0.050 |
Why?
|
| Kidney Transplantation | 1 | 2019 | 4262 | 0.050 |
Why?
|
| Microwaves | 1 | 2004 | 184 | 0.050 |
Why?
|
| Cells, Cultured | 3 | 2018 | 19015 | 0.050 |
Why?
|
| Heterozygote | 2 | 2020 | 2798 | 0.050 |
Why?
|
| Mice, Knockout | 4 | 2021 | 14488 | 0.050 |
Why?
|
| Neoplastic Stem Cells | 1 | 2010 | 1351 | 0.050 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2011 | 2062 | 0.050 |
Why?
|
| Anions | 1 | 2022 | 137 | 0.050 |
Why?
|
| Deamino Arginine Vasopressin | 1 | 2022 | 87 | 0.050 |
Why?
|
| Receptors, Vasopressin | 1 | 2022 | 106 | 0.050 |
Why?
|
| Adolescent | 9 | 2019 | 89169 | 0.050 |
Why?
|
| Neovascularization, Pathologic | 1 | 2012 | 2631 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 11095 | 0.050 |
Why?
|
| Aquaporin 2 | 1 | 2022 | 125 | 0.050 |
Why?
|
| Disease Progression | 4 | 2019 | 13671 | 0.050 |
Why?
|
| Melanoma, Experimental | 1 | 2004 | 559 | 0.050 |
Why?
|
| Cell Movement | 3 | 2020 | 5210 | 0.050 |
Why?
|
| Mutant Proteins | 1 | 2023 | 488 | 0.050 |
Why?
|
| RNA Interference | 1 | 2009 | 2832 | 0.040 |
Why?
|
| Amphibian Proteins | 1 | 2020 | 35 | 0.040 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2004 | 614 | 0.040 |
Why?
|
| Vasopressins | 1 | 2022 | 358 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 11928 | 0.040 |
Why?
|
| Pseudopodia | 1 | 2020 | 167 | 0.040 |
Why?
|
| HEK293 Cells | 2 | 2021 | 4283 | 0.040 |
Why?
|
| Amino Acid Transport System y+L | 1 | 2019 | 17 | 0.040 |
Why?
|
| alpha-Mannosidase | 1 | 2019 | 19 | 0.040 |
Why?
|
| Glomerular Basement Membrane | 1 | 2019 | 35 | 0.040 |
Why?
|
| Chloride-Bicarbonate Antiporters | 1 | 2019 | 103 | 0.040 |
Why?
|
| DNA Repair | 1 | 2009 | 2050 | 0.040 |
Why?
|
| Codon, Nonsense | 1 | 2021 | 287 | 0.040 |
Why?
|
| Anion Exchange Protein 1, Erythrocyte | 1 | 2019 | 150 | 0.040 |
Why?
|
| Complement C1q | 1 | 2019 | 93 | 0.040 |
Why?
|
| Down-Regulation | 2 | 2021 | 2937 | 0.040 |
Why?
|
| Skin Neoplasms | 2 | 2012 | 5863 | 0.040 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type IIa | 1 | 2019 | 44 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2012 | 3589 | 0.040 |
Why?
|
| Protein Stability | 1 | 2021 | 580 | 0.040 |
Why?
|
| Frameshift Mutation | 1 | 2021 | 392 | 0.040 |
Why?
|
| Nephritis, Hereditary | 1 | 2019 | 78 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2009 | 2954 | 0.040 |
Why?
|
| Family | 2 | 2020 | 3209 | 0.040 |
Why?
|
| Larva | 1 | 2020 | 515 | 0.040 |
Why?
|
| Cyclophosphamide | 1 | 2004 | 2227 | 0.040 |
Why?
|
| Zinc Fingers | 1 | 2021 | 577 | 0.040 |
Why?
|
| Integrins | 1 | 2023 | 842 | 0.040 |
Why?
|
| Kidney Glomerulus | 1 | 2020 | 570 | 0.040 |
Why?
|
| STAT1 Transcription Factor | 1 | 2019 | 343 | 0.040 |
Why?
|
| Dogs | 1 | 2023 | 3845 | 0.040 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2019 | 182 | 0.040 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2019 | 199 | 0.040 |
Why?
|
| Phosphate-Binding Proteins | 1 | 2018 | 93 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2019 | 687 | 0.040 |
Why?
|
| Consanguinity | 1 | 2019 | 460 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2018 | 267 | 0.030 |
Why?
|
| Disease Models, Animal | 4 | 2019 | 18349 | 0.030 |
Why?
|
| Cyclosporine | 1 | 2019 | 777 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2020 | 1505 | 0.030 |
Why?
|
| Genes, Recessive | 1 | 2018 | 625 | 0.030 |
Why?
|
| Infant, Newborn | 3 | 2021 | 26422 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2011 | 5703 | 0.030 |
Why?
|
| Tacrolimus | 1 | 2019 | 750 | 0.030 |
Why?
|
| Young Adult | 5 | 2019 | 60066 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2021 | 9561 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2018 | 1228 | 0.030 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2019 | 1120 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2018 | 2278 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2019 | 3623 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2019 | 1758 | 0.020 |
Why?
|
| Ovarian Neoplasms | 1 | 2009 | 4916 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2017 | 15454 | 0.020 |
Why?
|
| Angiopoietin-2 | 1 | 2012 | 186 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2021 | 5403 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2019 | 1896 | 0.020 |
Why?
|
| Adult | 6 | 2021 | 223646 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2019 | 2629 | 0.020 |
Why?
|
| Hospitals, Pediatric | 1 | 2019 | 1876 | 0.020 |
Why?
|
| Treatment Outcome | 4 | 2019 | 65371 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 2540 | 0.020 |
Why?
|
| Mediator Complex Subunit 1 | 1 | 2009 | 31 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2021 | 13421 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2018 | 1726 | 0.020 |
Why?
|
| Base Pair Mismatch | 1 | 2009 | 93 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 2009 | 6974 | 0.020 |
Why?
|
| Radiation, Ionizing | 1 | 2009 | 252 | 0.020 |
Why?
|
| Protein Binding | 1 | 2020 | 9343 | 0.020 |
Why?
|
| Graft Survival | 1 | 2019 | 3887 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 39348 | 0.020 |
Why?
|
| Seizures | 1 | 2021 | 2998 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2012 | 1083 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2009 | 730 | 0.020 |
Why?
|
| Computational Biology | 1 | 2019 | 3568 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2019 | 24315 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2009 | 1647 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2019 | 10101 | 0.020 |
Why?
|
| Boston | 1 | 2019 | 9374 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2019 | 3591 | 0.020 |
Why?
|
| Graft Rejection | 1 | 2019 | 4492 | 0.020 |
Why?
|
| Mice, Hairless | 1 | 2004 | 39 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2012 | 1369 | 0.010 |
Why?
|
| Rats | 1 | 2021 | 23760 | 0.010 |
Why?
|
| Skin Temperature | 1 | 2004 | 96 | 0.010 |
Why?
|
| Genotype | 1 | 2019 | 13045 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2017 | 6004 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2009 | 1151 | 0.010 |
Why?
|
| Cell Death | 1 | 2009 | 1679 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 13014 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 2009 | 1744 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2012 | 3740 | 0.010 |
Why?
|
| Genomics | 1 | 2019 | 5926 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 14729 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2009 | 8647 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2020 | 22291 | 0.010 |
Why?
|
| Mass Screening | 1 | 2018 | 5458 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 4580 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2012 | 2892 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2012 | 2981 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2009 | 2149 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2021 | 16045 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2009 | 2932 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 3800 | 0.010 |
Why?
|
| Wound Healing | 1 | 2012 | 2809 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 15948 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2004 | 1760 | 0.010 |
Why?
|
| Neoplasms | 1 | 2009 | 22371 | 0.010 |
Why?
|
| Incidence | 1 | 2018 | 21538 | 0.010 |
Why?
|
| DNA Damage | 1 | 2009 | 2469 | 0.010 |
Why?
|
| Remission Induction | 1 | 2004 | 2410 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2009 | 4528 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2009 | 4428 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 20760 | 0.010 |
Why?
|
| Middle Aged | 2 | 2019 | 223492 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2009 | 17140 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2004 | 8542 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 10760 | 0.010 |
Why?
|
| Risk Factors | 1 | 2017 | 74944 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2019 | 81762 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 171504 | 0.000 |
Why?
|